The nurse is discussing the current use of genetic testing and tamoxifen with a client who has breast cancer. Which information should the nurse include in this discussion?
Select all that apply.
Note: Credit will be given only if all correct choices and no incorrect choices are selected.
◦ The United States Agency of Healthcare Research and Quality recommends genetic testing for clients starting tamoxifen.
◦ Insurance providers in the United States do not support the use of CYP2D6 testing prior to prescribing tamoxifen.
◦ Dutch researchers support CYP2D6 testing prior to prescribing tamoxifen.
◦ Some European groups recommend using medications other than tamoxifen for women whose CYP2D6 testing reveals intermediate metabolizer status.
◦ Recommendations from across the globe vary as to the benefit of genetic testing prior to prescribing tamoxifen.
Genetic Transformation by DNA
Current Resistance and Voltage
Survey and posture of client: Lateral view
GENETIC ANALYSIS
Genomes Using Modifications of the Universal Genetic Code